Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KIMBERLY ELLEN JOHNSON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1942987144
CMS profile
11489733
Location
GREAT FALLS, MT

General Payments · PY2023–2024

$395.33

  • Reported across 15 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$377.96

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $377.96 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $166.60 2
Amgen Inc. $54.79 3
NOVARTIS PHARMACEUTICALS CORPORATION $52.73 3
GlaxoSmithKline, LLC. $26.83 2
ACADIA Pharmaceuticals Inc $23.78 1
Lilly USA, LLC $19.40 1
ABBVIE INC. $18.05 1
Neurocrine BioSciences, Inc. $15.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $17.37 1
PY2024 $377.96 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.05 09/12/2024 Food and Beverage Undisputed 01/23/2026 1107411453 CMS
ACADIA Pharmaceuticals Inc $23.78 07/16/2024 Food and Beverage Undisputed 01/23/2026 1148006278 CMS
Amgen Inc. $16.97 06/20/2024 Food and Beverage Undisputed 01/23/2026 1117590329 CMS
Amgen Inc. $15.60 07/25/2024 Food and Beverage Undisputed 01/23/2026 1117590331 CMS
Amgen Inc. $22.22 12/12/2024 Food and Beverage Undisputed 01/23/2026 1117590333 CMS
AstraZeneca Pharmaceuticals LP $153.46 01/15/2024 Food and Beverage Undisputed 01/23/2026 1105542669 CMS
AstraZeneca Pharmaceuticals LP $13.14 02/27/2024 Food and Beverage Undisputed 01/23/2026 1104355874 CMS
GlaxoSmithKline, LLC. $13.12 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116528780 CMS
GlaxoSmithKline, LLC. $13.71 12/05/2024 Food and Beverage Undisputed 01/23/2026 1116282903 CMS
Lilly USA, LLC $19.40 07/10/2024 Food and Beverage Undisputed 01/23/2026 1135798850 CMS
Neurocrine Biosciences, Inc. $15.78 05/01/2024 Food and Beverage Undisputed 01/23/2026 1151000700 CMS
Novartis Pharmaceuticals Corporation $14.94 03/26/2024 Food and Beverage Undisputed 01/23/2026 1087121260 CMS
Novartis Pharmaceuticals Corporation $16.80 05/16/2024 Food and Beverage Undisputed 01/23/2026 1087121274 CMS
Novartis Pharmaceuticals Corporation $20.99 08/08/2024 Food and Beverage Undisputed 01/23/2026 1087121272 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.